Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal

Abstract Views: 737
PDF: 1295
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The authors report two cases of active seropositive rheumatoid arthritis who were treated in an early phase of the disease with infliximab plus methotrexate obtaining a clinical remission. The benefit was maintained after the discontinuation of the anti-TNF alpha inhibitor for adverse events, indicating that the early administration of the drug may be followed by a sustained remission.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Caramaschi, P., Pieropan, S., Volpe, A., Carletto, A., Bambara, L., & Biasi, D. (2008). Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal. Reumatismo, 60(3), 221–223. https://doi.org/10.4081/reumatismo.2008.221